All Blogs

May 27, 2019

The U.S. FDA recently approved the much talked about Novartis’s drug Zolgensma for treating a life-threatening condition Spinal Muscular Atrophy (SMA).  SMA is a neuromuscular disorder that worsens the muscles over time. It happens due to a mutation in the SMN1 gene that results in the deficiency of an SMN protein,...

Sep 04, 2024

If you’ve been keeping up with our previous posts, you already have a solid understanding of nonalcoholic steatohepatitis (NASH) and its impact. We’ve previously examined the dominance of off-label therapies in the NASH therapeutics market and the challenges associated with this approach. In this post, we’ll take a...

May 23, 2019

Merck decides to acquire Peloton Therapeutics, fortifying Oncology pipeline Merck is ready to buy Peloton Therapeutics for USD 1.1 million. The companies have entered into a definitive agreement which will give Merck rights over an oral HIF-2α inhibitor- PT2977, which is Peloton’s lead candidate for the treatme...

May 22, 2019

NASH market share of off label therapies, it will keep on experiencing a steady growth until a standard approved therapy enters the NASH treatment market. Non-alcoholic fatty liver disease (NAFLD), is the most common group of conditions in which there is an excess fat accumulation in the liver in people who i...

May 30, 2019

Multiple Sclerosis Multiple Sclerosis is an unpredictable, autoimmune disease that affects the central nervous system. In this disease, the body's own immune system produces cells and proteins (antibodies), which attack the fatty substance,myelin that protects the nerve fibres. So, 30 May 2019 is globally obser...

May 21, 2019

FDA approves Fragmin- an anticoagulant for children   The FDA today approved Fragmin for the treatment of blood clots. Pfizer’s candidate Fragmin which was earlier approved for the treatment of only adults suffering from a fatal disease called VTE, which can include deep vein thrombosis (blood clot in the d...

May 20, 2019

The summer has arrived, and so has the season of Lyme. The number of Lyme disease cases invariably rises as the months of June and July approach. According to the CDC, the number of Lyme diseases diagnosed cases each year is 30,000. And this number is likely to cross 40,000 each year in the United States. The Lyme ...

May 17, 2019

Pulmonary Arterial Hypertension (PAH) is a chronic, life-alarming disease that advances over time. It is a rare disease characterized by the increased blood pressure in the arteries of the lungs. It is somehow different from normal high pressure in a way that blood pressure rises only in the arteries that carry blo...

May 17, 2019

World Hypertension Day The World Hypertension day is celebrated on May 17, 2019. The theme is Know Your Numbers with the aim to increase awareness of high blood pressure (BP) around the world and promote hypertension prevention, detection and control. Cardiovascular diseases occur due to high blood pre...

May 16, 2019

Ginkgo announces to buy Warp Drive Bio’s genome mining platform Ginkgo Bioworks has announced to acquire the genome mining platform from Warp Drive Bio, a subsidiary of REVOLUTION Medicines.  The acquisition will give Gingko access to Warp Drive Bio's genome mining team, technology, and database. This coll...